Filters

See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 37

Tests names and labsConditionsGenes and analytesMethods

AllNeuro panel

Centogene AG - the Rare Disease Company
Germany
6021038
  • C Sequence analysis of the entire coding region

PARK2 Parkinsonism

Centogene AG - the Rare Disease Company
Germany
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

TruGenome Predisposition Screen (Whole Genome Sequencing)

Illumina Clinical Services Laboratory Illumina
United States
15411578
  • C Sequence analysis of the entire coding region

PARK2. MLPA testing

Instituto de Medicina Genomica
Spain
11
  • D Deletion/duplication analysis

PARK2. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

Parkinson's Disease, Juvenile via the PARK2 Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

nucSEEKĀ® Comprehensive Sequence Analysis Of The Nuclear Mitochondrial Exome

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
560420
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

DYSTONIA

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
1513
  • C Sequence analysis of the entire coding region

PARKINSON DISEASE

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
1010
  • C Sequence analysis of the entire coding region

Parkinson Disease

Asper Biotech Asper Biotech Ltd.
Estonia
1716
  • C Sequence analysis of the entire coding region

PARK2(PARKIN) - Gene Sequencing & Del/Dup analysis

Genome Diagnostics VU University Medical Center
Netherlands
21
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • T Targeted variant analysis

NGS panel - Parkinson

Genome Diagnostics VU University Medical Center
Netherlands
2036
  • D Deletion/duplication analysis
  • S Mutation scanning of the entire coding region
  • T Targeted variant analysis

PARK2 Gene Sequencing

DDC Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children
United States
41
  • C Sequence analysis of the entire coding region

Parkinson disease type 2

Bioarray
Spain
11
  • D Deletion/duplication analysis

Parkinson disease 2 (PARK2, sequence analysis of PARK2 gene)

CGC Genetics
Portugal
11
  • C Sequence analysis of the entire coding region

Single gene testing PANK2

CeGaT GmbH
Germany
51
  • C Sequence analysis of the entire coding region

Parkinson disease (NGS panel for 33 genes)

CGC Genetics
Portugal
3032
  • C Sequence analysis of the entire coding region

Parkinson disease type 2 (PARK2, deletion/duplication analysis of PARK2 gene)

CGC Genetics
Portugal
11
  • D Deletion/duplication analysis

Parkinson disease (NGS panel for 10 genes)

CGC Genetics
Portugal
1110
  • C Sequence analysis of the entire coding region

Parkinson Syndrome, autosomal recessive Panel

CeGaT GmbH
Germany
911
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 37

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.